
Oral Transmucosal Drugs Market: By Product Type (Tablets, Films, Liquid & Spray, and Others), By Route of Administration (Sublingual Mucosa, Buccal Mucosa, and Others), By Indication (Opioid Dependence, Nausea and Vomiting, Erectile Dysfunction, Neurologi
Description
Oral Transmucosal Drugs Market: By Product Type (Tablets, Films, Liquid & Spray, and Others), By Route of Administration (Sublingual Mucosa, Buccal Mucosa, and Others), By Indication (Opioid Dependence, Nausea and Vomiting, Erectile Dysfunction, Neurological Disorders, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
Oral Transmucosal Drugs Market: By Product Type (Tablets, Films, Liquid & Spray, and Others), By Route of Administration (Sublingual Mucosa, Buccal Mucosa, and Others), By Indication (Opioid Dependence, Nausea and Vomiting, Erectile Dysfunction, Neurological Disorders, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) And Region - Global Analysis of Market Size, Share & Trends For 2021-2022 And Forecasts To 2032
PRODUCT OVERVIEW
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected to reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032
Oral transmucosal delivery means systemic administration of medication via the mucous membrane of the oral cavity. The transmucosal drug delivery system has various benefits making it profitable market. Transmucosal drug delivery permits drugs to bypass the body's natural defence mechanisms and are available in dosage forms like tablets, gels, thin films and they dissolve in the mouth. Oral transmucosal drugs can bypass hepatic first-pass metabolism and avoid degradation of drugs in the gastrointestinal tract.
MARKET HIGHLIGHTS
The Global Oral Transmucosal Drugs Market was valued at 28.65 billion USD in 2021 and is expected to reach 58.2 billion USD by 2032, increasing at a CAGR of 6.7% during the forecast period, i.e., 2022-2032 owing to increasing incidence of respiratory problems, autoimmune disorders, cancer, mucositis etc. The people getting affected by autoimmune disorders, respiratory problems, oral cancer, etc. are increasing leading to rise of the market across the world. This increases the requirement of oral transmucosal drugs to prevent gastrointestinal degradation and provide rapid onset of action. The number of patients with chronic diseases is rising across the world which increases the pre-surgical procedures which is expected to boost the global oral transmucosal drugs market.
Global Oral Transmucosal Drugs Market Segments
- By Product Type
- Tablets
- Films
- Liquid & Spray
- Others
- By Route of Administration
- Sublingual Mucosa
- Buccal Mucosa
- Others
- By Indication
- Opioid Dependence
- Nausea and Vomiting
- Erectile Dysfunction
- Neurological Disorders
- Others
- By Distribution Channel
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Growth Drivers
Incidence of chronic diseases may boost the market growth
Rising R&D activities may drive the market growth
Restraint
High Cost may restrain the market growth
Key Players
- ZIM Laboratories Limited
- Aquestive Therapeutics, Inc.
- IntelGenx Corp.
- C.L.Pharm Co., Ltd.
- Novartis AG
- Seoul Pharmaceuticals
- Pfizer Inc.
- Shilpa Therapeutics
- Teva Pharmaceutical Industries Ltd.
- Sunovion Pharmaceuticals, Inc.
- Other Prominent Players
Global Laboratory Temperature Control Units Market is further segmented by region into:
- North America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAG.R – United States and Canada
- Latin America Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – Mexico, Argentina, Brazil and Rest of Latin America
- Europe Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – United Kingdom, France, Germany, Italy, Spain, Belgium, Hungary, Luxembourg, Netherlands, Poland, NORDIC, Russia, Turkey and Rest of Europe
- Asia Pacific Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – India, China, South Korea, Japan, Malaysia, Indonesia, New Zealand, Australia and Rest of APAC
- Middle East and Africa Market Size, Share, Trends, Opportunities, Y-o-Y Growth, CAGR – North Africa, Israel, GCC, South Africa and Rest of MENA
- Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 3-month post-sales analyst support.
Table of Contents
411 Pages
- 1 Executive Summary
- 1.1. Regional Market Share
- 1.2. Business Trends
- 1.3. Global Oral Transmucosal Drugs Market: COVID-19 Outbreak
- 1.4. Regional Trends
- 1.5. Segmentation Snapshot
- 2 Research Methodology
- 2.1. Research Objective
- 2.2. Research Approach
- 2.3. Data Sourcing and Methodology
- 2.4. Primary Research
- 2.5. Secondary Research
- 2.5.1. Paid Sources
- 2.5.2. Public Sources
- 2.6. Market Size Estimation and Data Triangulation
- 3 Market Characteristics
- 3.1. Market Definition
- 3.2. Global Oral Transmucosal Drugs Market: COVID-19 Impact
- 3.3. Key Segmentations
- 3.4. Key Developments
- 3.5. Allied Industry Data
- 4 Global Oral Transmucosal Drugs Market – Industry Insights
- 4.1. Industry Segmentation
- 4.2. COVID-19 overview on world economy
- 4.3. Industry ecosystem Channel analysis
- 4.4. Innovation & Sustainability
- 5 Macroeconomic Indicators
- 6 Recent Developments
- 7 Market Dynamics
- 7.1. Introduction
- 7.2. Growth Drivers
- 7.3. Market Opportunities
- 7.4. Market Restraints
- 7.5. Market Trends
- 8 Risk Analysis
- 9 Market Analysis
- 9.1. Porters Five Forces
- 9.2. PEST Analysis
- 9.2.1. Political
- 9.2.2. Economic
- 9.2.3. Social
- 9.2.4. Technological
- 10 Global Oral Transmucosal Drugs Market
- 10.1. Overview
- 10.2. Historical Analysis (2016-2021)
- 10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
- 11 Global Oral Transmucosal Drugs Market Size & Forecast 2022A-2032F
- 11.1. Overview
- 11.2. Key Findings
- 11.3. Market Segmentation
- 11.3.1. By Product Type
- 11.3.1.1. Tablets
- 11.3.1.1.1. By Value (USD Million) 2022-2032F
- 11.3.1.1.2. Market Share (%) 2022-2032F
- 11.3.1.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.2. Films
- 11.3.1.2.1. By Value (USD Million) 2022-2032F
- 11.3.1.2.2. Market Share (%) 2022-2032F
- 11.3.1.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.3. Liquid & Spray
- 11.3.1.3.1. By Value (USD Million) 2022-2032F
- 11.3.1.3.2. Market Share (%) 2022-2032F
- 11.3.1.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.1.4. Others
- 11.3.1.4.1. By Value (USD Million) 2022-2032F
- 11.3.1.4.2. Market Share (%) 2022-2032F
- 11.3.1.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2. By Route of Administration
- 11.3.2.1. Sublingual Mucosa
- 11.3.2.1.1. By Value (USD Million) 2022-2032F
- 11.3.2.1.2. Market Share (%) 2022-2032F
- 11.3.2.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.2. Buccal Mucosa
- 11.3.2.2.1. By Value (USD Million) 2022-2032F
- 11.3.2.2.2. Market Share (%) 2022-2032F
- 11.3.2.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.2.3. Others
- 11.3.2.3.1. By Value (USD Million) 2022-2032F
- 11.3.2.3.2. Market Share (%) 2022-2032F
- 11.3.2.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3. By Indication
- 11.3.3.1. Opioid Dependence
- 11.3.3.1.1. By Value (USD Million) 2022-2032F
- 11.3.3.1.2. Market Share (%) 2022-2032F
- 11.3.3.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.2. Nausea and Vomiting
- 11.3.3.2.1. By Value (USD Million) 2022-2032F
- 11.3.3.2.2. Market Share (%) 2022-2032F
- 11.3.3.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.3. Erectile Dysfunction
- 11.3.3.3.1. By Value (USD Million) 2022-2032F
- 11.3.3.3.2. Market Share (%) 2022-2032F
- 11.3.3.3.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.4. Neurological Disorders
- 11.3.3.4.1. By Value (USD Million) 2022-2032F
- 11.3.3.4.2. Market Share (%) 2022-2032F
- 11.3.3.4.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.3.5. Others
- 11.3.3.5.1. By Value (USD Million) 2022-2032F
- 11.3.3.5.2. Market Share (%) 2022-2032F
- 11.3.3.5.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4. By Distribution Channel
- 11.3.4.1. Hospital Pharmacies
- 11.3.4.1.1. By Value (USD Million) 2022-2032F
- 11.3.4.1.2. Market Share (%) 2022-2032F
- 11.3.4.1.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.2. Retail Pharmacies
- 11.3.4.2.1. By Value (USD Million) 2022-2032F
- 11.3.4.2.2. Market Share (%) 2022-2032F
- 11.3.4.2.3. Y-o-Y Growth (%) 2022-2032F
- 11.3.4.3. Online Pharmacies
- 11.3.4.3.1. By Value (USD Million) 2022-2032F
- 11.3.4.3.2. Market Share (%) 2022-2032F
- 11.3.4.3.3. Y-o-Y Growth (%) 2022-2032F
- 12 North America Oral Transmucosal Drugs Market Size & Forecast 2022A-2032F
- 12.1. Overview
- 12.2. Key Findings
- 12.3. Market Segmentation
- 12.3.1. By Product Type
- 12.3.2. By Route of Administration
- 12.3.3. By Indication
- 12.3.4. By Distribution Channel
- 12.4. Country
- 12.4.1. United States
- 12.4.2. Canada
- 13 Europe Oral Transmucosal Drugs Market Size & Forecast 2022A-2032F
- 13.1. Overview
- 13.2. Key Findings
- 13.3. Market Segmentation
- 13.3.1. By Product Type
- 13.3.2. By Route of Administration
- 13.3.3. By Indication
- 13.3.4. By Distribution Channel
- 13.4. Country
- 13.4.1. Germany
- 13.4.2. United Kingdom
- 13.4.3. France
- 13.4.4. Italy
- 13.4.5. Spain
- 13.4.6. Russia
- 13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
- 14 Asia Oral Transmucosal Drugs Market Size & Forecast 2022A-2032F
- 14.1. Overview
- 14.2. Key Findings
- 14.3. Market Segmentation
- 14.3.1. By Product Type
- 14.3.2. By Route of Administration
- 14.3.3. By Indication
- 14.3.4. By Distribution Channel
- 14.4. By Country
- 14.4.1. India
- 14.4.2. China
- 14.4.3. South Korea
- 14.4.4. Japan
- 14.4.5. Rest of APAC
- 15 Middle East and Africa Oral Transmucosal Drugs Market Size & Forecast 2022A-2032F
- 15.1. Overview
- 15.2. Key Findings
- 15.3. Market Segmentation
- 15.3.1. By Product Type
- 15.3.2. By Route of Administration
- 15.3.3. By Indication
- 15.3.4. By Distribution Channel
- 15.4. Country
- 15.4.1. Israel
- 15.4.2. GCC
- 15.4.3. North Africa
- 15.4.4. South Africa
- 15.4.5. Rest of Middle East and Africa
- 16 Latin America Oral Transmucosal Drugs Market Size & Forecast 2022A-2032F
- 16.1. Overview
- 16.2. Key Findings
- 16.3. Market Segmentation
- 16.3.1. By Product Type
- 16.3.2. By Route of Administration
- 16.3.3. By Indication
- 16.3.4. By Distribution Channel
- 16.4. Country
- 16.4.1. Mexico
- 16.4.2. Brazil
- 16.4.3. Rest of Latin America
- 17 Competitive Landscape
- 17.1. Company market share, 2021
- 17.2. Key player overview
- 17.3. Key stakeholders
- 18 Company Profiles
- 18.1. ZIM Laboratories Limited
- 18.1.1. Company Overview
- 18.1.2. Financial Overview
- 18.1.3. Key Product; Analysis
- 18.1.4. Company Assessment
- 18.1.4.1. Product Portfolio
- 18.1.4.2. Key Clients
- 18.1.4.3. Market Share
- 18.1.4.4. Recent News & Development (Last 3 Yrs.)
- 18.1.4.5. Executive Team
- 18.2. Aquestive Therapeutics, Inc.
- 18.3. IntelGenx Corp.
- 18.4. C.L.Pharm Co., Ltd.
- 18.5. Novartis AG
- 18.6. Seoul Pharmaceuticals
- 18.7. Pfizer Inc.
- 18.8. Shilpa Therapeutics
- 18.9. Teva Pharmaceutical Industries Ltd.
- 18.10. Sunovion Pharmaceuticals, Inc.
- 18.11. Other Prominent Players
- 19 Appendix
- 20 Consultant Recommendation
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.